Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoid Tumor × veliparib × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 6 Breast Neoplasms 6 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Thrombocythemia, Essential 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

zimberelimab 1 pembrolizumab 1 olaparib 1 lutetium Lu 177 dotatate 1 lanreotide 1 cabozantinib 1 Sunitinib 1 Random Allocation 1 Octreotide 1 Nivolumab 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡